TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
HAE

Haemonetics Corporation

Healthcare · Medical Devices

104.70$ +0.3% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Haemonetics Corporation (HAE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 2,365 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet HAE
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
1,335 1,306 1,239 1,251 1,271 1,312 1,237 1,241 1,266 1,228 1,275 1,260 1,191 1,238 1,267 1,433 1,418 1,318 1,820 1,794 1,801 1,831 1,860 1,821 1,865 1,878 1,935 1,962 2,011 2,200 2,196 2,541 2,525 2,531 2,451 2,462 2,442 2,491 2,396 2,365
512 497 510 528 553 590 521 551 553 516 576 615 568 583 604 759 760 668 694 684 699 729 756 688 716 706 770 802 866 765 769 979 956 1,006 935 913 900 944 835 811
139 130 140 172 204 252 180 192 200 155 169 190 112 126 137 276 279 189 192 173 192 237 259 215 241 224 284 286 351 194 179 344 299 321 307 293 296 363 245 223
139 130 140 172 204 252 180 192 200 155 169 190 112 126 137 276 279 189 192 173 192 237 259 215 241 224 284 286 351 194 179 344 299 321 307 293 296 363 245 223
152 151 153 152 144 147 151 151 162 168 185 163 177 171 165 141 142 147 128 133 141 155 159 146 172 181 179 177 174 212 207 201 214 212 203 201 207 196 217 216
195 188 177 174 169 159 161 175 164 169 194 222 245 254 270 295 305 300 323 327 323 306 293 278 255 256 259 289 286 304 317 374 382 360 365 361 336 321 306 307
340 336 324 322 320 330 332 316 345 351 344 277 284 268 253 243 240 240 277 215 224 239 258 288 308 313 311 304 308 – – – 300 286 284 287 292 297 – –
269 267 211 211 211 211 211 211 211 211 211 211 211 211 211 217 215 216 466 466 469 468 467 466 465 466 466 466 465 555 565 613 616 605 604 607 606 607 656 657
192 185 178 173 169 164 157 149 141 135 128 120 114 107 133 138 127 120 365 354 337 324 310 303 293 284 276 268 251 429 406 495 488 466 456 451 428 420 448 435
586 536 499 479 470 489 485 567 564 585 607 669 607 663 680 825 750 599 1,088 1,117 1,103 1,101 1,110 1,050 1,136 1,102 1,117 1,098 1,118 1,257 1,236 1,636 1,646 1,624 1,630 1,580 1,593 1,579 1,600 1,528
199 216 211 206 255 324 385 194 189 211 236 294 240 257 275 408 339 194 253 228 288 355 442 180 262 227 252 237 264 262 300 260 274 253 578 531 548 540 283 263
52 66 61 66 109 151 194 17 13 17 28 118 57 62 84 231 167 17 25 17 83 144 221 6.9 58 9.9 12 14 14 14 10 5.1 5.4 5.1 304 304 304 305 5.0 5.0
42 49 43 39 42 41 55 65 58 63 63 61 57 52 51 48 49 43 50 49 45 51 58 58 61 64 64 78 80 57 73 77 69 63 67 46 62 49 51 56
337 270 254 237 178 119 59 331 331 327 322 318 314 310 306 297 297 293 691 767 698 633 559 763 760 757 754 751 749 857 798 1,218 1,220 1,220 921 921 920 920 1,220 1,169
749 771 740 773 801 823 752 674 701 643 668 591 584 575 587 609 668 719 732 677 699 731 749 770 729 776 818 865 894 943 960 905 879 907 821 882 849 911 796 837
326 341 290 310 330 324 267 190 194 141 161 99 86 70 79 89 137 169 158 155 169 193 202 222 204 224 253 284 309 340 360 387 369 392 352 356 336 381 279 312
52 52 52 53 53 53 54 52 53 53 52 51 52 52 51 51 51 51 51 51 51 51 51 52 52 51 51 51 51 51 51 52 51 51 49 48 48 47 46 46

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?